Clinical, biological, and genome-wide comparison of carbapenem-resistant <em>Klebsiella pneumoniae</em> with susceptibility transformation to polymyxin B during therapy

Publication date: Available online 7 July 2023Source: Clinical Microbiology and InfectionAuthor(s): Yuan Wang, Tao Chen, Xiaohui Chi, Yanzi Zhou, Hao Fu, Ping Lu, Luying Xiong, Tingting Xiao, Beiwen Zheng, Ping Shen, Qixia Luo, Yonghong Xiao

Clinical, biological, and genome-wide comparison of carbapenem-resistant <em>Klebsiella pneumoniae</em> with susceptibility transformation to polymyxin B during therapy

Publication date: Available online 7 July 2023Source: Clinical Microbiology and InfectionAuthor(s): Yuan Wang, Tao Chen, Xiaohui Chi, Yanzi Zhou, Hao Fu, Ping Lu, Luying Xiong, Tingting Xiao, Beiwen Zheng, Ping Shen, Qixia Luo, Yonghong Xiao

A pilot phase 2a, randomised, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalised adults with respiratory syncytial virus (RSV) infection

Publication date: Available online 6 July 2023Source: Clinical Microbiology and InfectionAuthor(s): Anna C. Nilsson, John Pullman, Piotr Napora, Kleber Luz, Anil Gupta, Jorge Draghi, Ana Karla Guzman Romero, Naresh Aggarwal, Galina Petrova, Juliana Ian…